Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on August 2, 2025

3 Unstoppable Stocks to Buy in August

Motley Fool

6 hours ago

3 Unstoppable Stocks to Buy in August

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week

The Wall Street Journal

20 hours ago

McDonald’s, Palantir, Novo Nordisk Earnings: What to Watch Next Week

KBRA Assigns Preliminary Ratings to VRTX 2025-HQ

Business Wire

a day ago

KBRA Assigns Preliminary Ratings to VRTX 2025-HQ

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now

Motley Fool

a day ago

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now

Stay Ahead of the Game With Vertex (VRTX) Q2 Earnings: Wall Street's Insights on Key Metrics

Zacks

3 days ago

Stay Ahead of the Game With Vertex (VRTX) Q2 Earnings: Wall Street's Insights on Key Metrics

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Zacks

4 days ago

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

4 days ago

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?

Zacks

4 days ago

Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

4 days ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

LEAD3R Launches 2025 Healthy Team Summit, Sponsored by The Future of Teamwork Podcast

PR Newswire

4 days ago

LEAD3R Launches 2025 Healthy Team Summit, Sponsored by The Future of Teamwork Podcast

CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?

Zacks

5 days ago

CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?

Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

5 days ago

Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth

The 3 Things That Matter for Vertex Pharmaceuticals Now

Motley Fool

5 days ago

The 3 Things That Matter for Vertex Pharmaceuticals Now

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q1 Earnings?

StockStory

6 days ago

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q1 Earnings?

Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment

Insider Monkey

8 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment

REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?

Zacks

8 days ago

REGN Q2 Earnings: Will Higher Dupixent Profits Fuel Growth?

A Look At The Fair Value Of Vertex, Inc. (NASDAQ:VERX)

Simply Wall St.

8 days ago

A Look At The Fair Value Of Vertex, Inc. (NASDAQ:VERX)

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts

Zacks

10 days ago

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts

Vertex Pharmaceuticals (VRTX) Advances Cystic Fibrosis Treatment With ALYFTREK Approval in Canada

Simply Wall St.

10 days ago

Vertex Pharmaceuticals (VRTX) Advances Cystic Fibrosis Treatment With ALYFTREK Approval in Canada

Zai Lab Limited (ZLAB) Stock Jumps 6.8%: Will It Continue to Soar?

Zacks

10 days ago

Zai Lab Limited (ZLAB) Stock Jumps 6.8%: Will It Continue to Soar?

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Zacks

11 days ago

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

MT Newswires

11 days ago

Vertex Pharmaceuticals Gets Marketing Authorization for Cystic Fibrosis Treatment in Canada

Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis

CNW Group

11 days ago

Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis

Vertex Pharmaceuticals' Quarterly Earnings Preview: What You Need to Know

Barchart

11 days ago

Vertex Pharmaceuticals' Quarterly Earnings Preview: What You Need to Know

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results

Motley Fool

11 days ago

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results

3 Top Growth Stocks to Buy in the Second Half of 2025

Motley Fool

14 days ago

3 Top Growth Stocks to Buy in the Second Half of 2025

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Zacks

17 days ago

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

17 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

Zacks

18 days ago

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

18 days ago

Exploring 3 High Growth Tech Stocks In The US Market

Vertex Pharmaceuticals (VRTX) Secures NHS England Agreement For Next-In-Class Cystic Fibrosis Treatment

Simply Wall St.

18 days ago

Vertex Pharmaceuticals (VRTX) Secures NHS England Agreement For Next-In-Class Cystic Fibrosis Treatment

EU Commission Approves Vertex Pharmaceutical’s (VRTX) Cystic Fibrosis Treatment

Insider Monkey

18 days ago

EU Commission Approves Vertex Pharmaceutical’s (VRTX) Cystic Fibrosis Treatment

Vertex and NHS England agree reimbursement for Alyftrek

Pharmaceutical Technology

18 days ago

Vertex and NHS England agree reimbursement for Alyftrek

Vertex Pharmaceuticals And 2 Other Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

18 days ago

Vertex Pharmaceuticals And 2 Other Stocks That May Be Trading Below Their Estimated Value

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug

BioPharma Dive

18 days ago

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug

Vertex Announces Broad Reimbursement Agreement With NHS England for ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor) an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire

19 days ago

Vertex Announces Broad Reimbursement Agreement With NHS England for ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor) an Innovative Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain

Business Wire

19 days ago

Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain

My 3 Top Stocks to Buy in a Market That's Highly Volatile (Again)

Motley Fool

19 days ago

My 3 Top Stocks to Buy in a Market That's Highly Volatile (Again)

The Best Stocks to Invest $1,000 in Right Now

Motley Fool

21 days ago

The Best Stocks to Invest $1,000 in Right Now

Suzetrigine: a new era in non-opioid pain relief

Clinical Trials Arena

23 days ago

Suzetrigine: a new era in non-opioid pain relief

Morningstar Research

24 days ago

Analyst Report: CRISPR Therapeutics AG

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

CNW Group

24 days ago

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

Vertex to Announce Second Quarter 2025 Financial Results on August 4th

Business Wire

25 days ago

Vertex to Announce Second Quarter 2025 Financial Results on August 4th

Vertex Protocol Team to Join Ink Foundation, Build New DeFi Primitives on Ink Layer-2

PR Newswire

25 days ago

Vertex Protocol Team to Join Ink Foundation, Build New DeFi Primitives on Ink Layer-2

Do You Believe in the Upside Potential of Vertex Pharmaceuticals (VRTX)?

Insider Monkey

25 days ago

Do You Believe in the Upside Potential of Vertex Pharmaceuticals (VRTX)?

Intellia Gains 29.8% in a Month: How Should You Play the Stock?

Zacks

a month ago

Intellia Gains 29.8% in a Month: How Should You Play the Stock?

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

CNW Group

a month ago

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

MT Newswires

a month ago

RBC Raises Price Target on Vertex Pharmaceuticals to $430 From $420, Keeps Sector Perform Rating

3 No-Brainer Stocks to Buy in July

Motley Fool

a month ago

3 No-Brainer Stocks to Buy in July

The Best Stocks to Invest $1,000 In Right Now

Motley Fool

a month ago

The Best Stocks to Invest $1,000 In Right Now

Vertex reports long-term results for Casgevy in sickle cell and thalassaemia

Clinical Trials Arena

a month ago

Vertex reports long-term results for Casgevy in sickle cell and thalassaemia

MT Newswires

a month ago

Vertex Says Long-Term Data Show Casgevy's 'Durable' Clinical Benefits in Blood Disorder Trials

Vertex Presents Longer-Term Data at the 2025 European Hematology Association (EHA) Congress Demonstrating Durability of CASGEVY® and Provides Update on Expanding Global Access to CASGEVY

CNW Group

a month ago

Vertex Presents Longer-Term Data at the 2025 European Hematology Association (EHA) Congress Demonstrating Durability of CASGEVY® and Provides Update on Expanding Global Access to CASGEVY

Vertex Pharmaceuticals (NasdaqGS:VRTX) Secures EU Approval for New CF Treatment Access

Simply Wall St.

a month ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Secures EU Approval for New CF Treatment Access

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek

Zacks

a month ago

Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

Pharmaceutical Technology

a month ago

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts

MT Newswires

a month ago

Vertex Pharmaceuticals Says European Commission Approves Alyftrek for Treating Cystic Fibrosis

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire

a month ago

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

AbbVie to buy Capstan for up to $2.1 billion in immunology push

Reuters

a month ago

AbbVie to buy Capstan for up to $2.1 billion in immunology push

Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?

Zacks

a month ago

Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?

H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results

Insider Monkey

a month ago

H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results

Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug

Insider Monkey

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call

StockStory

a month ago

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

Zacks

a month ago

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

Vertex Pharmaceuticals Presents “Unprecedented” Data for T1D Cell Therapy Zimislecel, Shows Durable Benefit

Insider Monkey

a month ago

Vertex Pharmaceuticals Presents “Unprecedented” Data for T1D Cell Therapy Zimislecel, Shows Durable Benefit

Clinical Trials Arena

a month ago

Vertex presents data from Phase I/II stage of trial for type 1 diabetes

MT Newswires

a month ago

Vertex Pharmaceuticals, Ono Sign License Deal for Povetacicept in Japan, South Korea

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

Business Wire

a month ago

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

Business Wire

a month ago

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

Zacks

a month ago

Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake

Insider Monkey

a month ago

Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake

MT Newswires

a month ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $460 From $464

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

Zacks

a month ago

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

2 Growth Stocks to Buy and Hold for 10 Years

Motley Fool

a month ago

2 Growth Stocks to Buy and Hold for 10 Years

MT Newswires

2 months ago

RBC Capital Adjusts PT on Vertex Pharmaceuticals to $420 From $423, Maintains Sector Perform Rating

Exploring High Growth Tech Stocks In The US This June 2025

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks In The US This June 2025

3 Stocks Estimated To Be Trading At A Discount Of Up To 48.1%

Simply Wall St.

2 months ago

3 Stocks Estimated To Be Trading At A Discount Of Up To 48.1%

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Motley Fool

2 months ago

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know

Vertex Presents New Data on the Benefits of ALYFTREK

Insider Monkey

2 months ago

Vertex Presents New Data on the Benefits of ALYFTREK

1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore

StockStory

2 months ago

1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore

Vertex Pharmaceuticals (NasdaqGS:VRTX) Highlights Clinical Benefits Of ALYFTREK At Cystic Fibrosis Conference

Simply Wall St.

2 months ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Highlights Clinical Benefits Of ALYFTREK At Cystic Fibrosis Conference

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference

Business Wire

2 months ago

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference

Why Is Apellis Pharmaceuticals (APLS) Up 7.2% Since Last Earnings Report?

Zacks

2 months ago

Why Is Apellis Pharmaceuticals (APLS) Up 7.2% Since Last Earnings Report?

Cytokinetics (CYTK) Down 1.9% Since Last Earnings Report: Can It Rebound?

Zacks

2 months ago

Cytokinetics (CYTK) Down 1.9% Since Last Earnings Report: Can It Rebound?

Vertex (VRTX) Down 0.8% Since Last Earnings Report: Can It Rebound?

Zacks

2 months ago

Vertex (VRTX) Down 0.8% Since Last Earnings Report: Can It Rebound?

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

2 months ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

3 No-Brainer Healthcare Stocks to Buy in June

Motley Fool

2 months ago

3 No-Brainer Healthcare Stocks to Buy in June

2 Top Stocks to Buy Right Now

Motley Fool

2 months ago

2 Top Stocks to Buy Right Now

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

StockStory

2 months ago

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Motley Fool

2 months ago

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

StockStory

2 months ago

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

3 Top Growth Stocks to Buy in the Second Half of 2025

Motley Fool

2 months ago

3 Top Growth Stocks to Buy in the Second Half of 2025

2 Monster Growth Stocks to Buy and Hold for 10 Years

Motley Fool

2 months ago

2 Monster Growth Stocks to Buy and Hold for 10 Years

MT Newswires

2 months ago

Argus Adjusts Price Target on Vertex Pharmaceuticals to $525 From $550

Argus Research

2 months ago

Analyst Report: Vertex Pharmaceuticals, Inc.

Argus Research

2 months ago

Market Digest: AIG, HST, PSA, VRTX

Share on Social Networks: